date/time interval
- September 23, 2022 - August 31, 2029
Optimization of an HCN1-selective inverse agonist for the treatment of peripheral neuropathic pain
Grant
Overview
awarded by
administered by
sponsor award ID
- 1 R42 NS129370-01
Affiliation
contributor
- Goldstein, Peter A Principal Investigator (Subaward) 2022 - 2029